In early-stage breast cancer patients, low levels of TET1 mRNA were associated with poor survival rates, and in breast cancer cell line and mouse xenograft models, TET1 was reported to regulate tumor growth and metastasis by demethylating HOXA7 and HOXA9 promoter regions. Here, HOXA7 is linked to breast carcinoma.